McKesson fourth-quarter profit tops forecasts
May 12 (Reuters) - U.S. drug wholesaler McKesson Corp on Monday said profit rose in the latest quarter, exceeding analyst expectations, thanks to strength in its distribution and technology solutions units.
For the fiscal fourth quarter ended March 31, the company posted net income of $371 million, up from $259 million in the year-earlier period. On a per share basis, net income from continuing operations rose to $1.56 from $1.11.
Excluding special items, earnings from continuing operations were $2.55 a share.
On that basis, analysts on average expected earnings of $2.40 per share, according to Thomson Reuters I/B/E/S.
Revenue rose 25 percent to $38.14 billion, which was above Wall Street expectations of $35.86 billion. (Reporting by Susan Kelly in Chicago; Editing by David Gregorio)
- Sierra Leone declares emergency as Ebola death toll hits 729 |
- S&P500 index posts worst fall since April; indexes down for July
- U.S. man sues soccer star Cristiano Ronaldo over CR7 trademark
- Israel, Palestinian militant groups agree to three-day Gaza truce |
- Moscow fights back after sanctions; battle rages near Ukraine crash site |